Brief: Chemours Expects Q2 Consolidated Net Sales At High End Of Original Range
June 18 (Reuters) - Chemours Co CC.N: THE CHEMOURS COMPANY PROVIDES UPDATE ON SECOND QUARTER 2025 OUTLOOK CHEMOURS CO - TSS ANTICIPATES 25% SEQUENTIAL INCREASE IN Q2 NET SALES CHEMOURS CO - Q2 CONSOLIDATED NET SALES EXPECTED AT HIGH END OF ORIGINAL RANGE CHEMOURS CO - Q2 CONSOLIDATED ADJUSTED EBITDA PROJECTED BETWEEN $215 AND $225 MILLION CHEMOURS: ANTICIPATES OVERALL CORPORATE COSTS FOR Q2 TO BE SLIGHTLY HIGHER-THAN-EXPECTED Further company coverage: CC.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on The Chemours
See all newsUS RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval